Hetero enters into a licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of ‘Remdesivir’ in 127 countries, including India for COVID-19
INDIA, HYDERABAD, 13th MAY, 2020 (GPN): Hetero, one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs, announced today that it has entered into a licensing agreement with Gilead Sciences, Inc….